4 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow apararenone: new trials by email Literature Review of apararenone trials Research Report on apararenone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) MT-3995, Placebo - NASH | Phase 2 | Completed | Tanabe Pharma Corporation | 48 | 2016-09-01 | 2019-09-06 |
| Mass Balance Study of MT-3995 MT-3995 - Healthy | Phase 1 | Completed | Tanabe Pharma Corporation | 9 | 2016-08-01 | 2017-01-31 |
| Drug Interaction Study of Warfarin and MT-3995 Warfarin, MT-3995 - Healthy | Phase 1 | Completed | Tanabe Pharma Corporation | 20 | 2015-06-01 | 2015-10-09 |
| Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy MT-3995, Placebo - Diabetic Nephropathy | Phase 1 / Phase 2 | Completed | Tanabe Pharma Corporation | 31 | 2014-07-01 | 2015-09-16 |
Japan (2) · Germany (1) · United Kingdom (1)
Horst Heuer, Dr (1) · Kazuoki Kondou, Adviļ½er (1) · Masaomi Nangaku, Professor (1)